Nanoformulated Recombinant Human Myelin Basic Protein and Rituximab Modulate Neuronal Perturbations in Experimental Autoimmune Encephalomyelitis in Mice

Muhammed A Saad,1,2 Noha M Eissa,2 Mohammed A Ahmed,3 Aliaa N ElMeshad,3,4 Götz Laible,5– 7 Ahmed S Attia,8 Medhat A Al-Ghobashy,9,10 Rania M Abdelsalam,1,2 Muhammad Y Al-Shorbagy1,11 1Department of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, Cairo, Egypt; 2School of Pharmacy...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Saad MA, Eissa NM, Ahmed MA, ElMeshad AN, Laible G, Attia AS, Al-Ghobashy MA, Abdelsalam RM, Al-Shorbagy MY
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Dove Medical Press 2022-09-01
Colecção:	International Journal of Nanomedicine
Assuntos:	multiple sclerosis experimental autoimmune encephalomyelitis nanoparticle rituximab recombinant human myelin basic protein
Acesso em linha:	https://www.dovepress.com/nanoformulated-recombinant-human-myelin-basic-protein-and-rituximab-mo-peer-reviewed-fulltext-article-IJN
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!